Oncternal Therapeutics Inc

NASDAQ:ONCT   3:59:43 PM EDT
4.97
-0.11 (-2.16%)
Equity Financing / Related

Oncternal Therapeutics Increases Previously Announced Bought Deal To $75 Mln

Published: 12/10/2020 05:31 GMT
Oncternal Therapeutics Inc (ONCT) - Oncternal Therapeutics Increases Previously Announced Bought Deal to $75.0 Million.
Oncternal Therapeutics- Increased Size of Offering, Purchase on a Firm Commitment Basis 16.7 Million Shares of Stock at Price of $4.50 per Share.
Oncternal Therapeutics- Intends to Use Proceeds for Expenses Related to Development of Some Therapies.